The selective killing effect of adenoviral mediated HSV-tk/GCV suicide gene system controlled by hTERT promoter on bladder cancer cells

被引:0
|
作者
王亚轩
机构
[1] Shijiazhuang 050000
[2] 2nd Hos
[3] Dept Urol
[4] Hebei Med Univ
关键词
D O I
暂无
中图分类号
R737.14 [膀胱肿瘤];
学科分类号
100214 ;
摘要
To investigate the selective killing effect of adenoviral mediated herpes simplex virus-thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene system controlled by human telomerase reverse transcriptase (hTERT) promoter on bladder cancer cells in vitro.Methods Bladder cancer cell line 253J and human fibroblast cell line MRC-5 were transfected by the recombinant adenovirus of different multiplicities of infection (MOI),and the infection rate was measured by observing the expression of enhanced green fluorescent protein (EGFP) under the fluorescent microscopy.Ad-hTERT-HSV/tk and Ad-CMV-SHV/tk were transduced into 253J and MRC-5,followed by GCV treatment.The relative survival rate of cells in presence of prodrug GCV was measured with MTT method.Results Recombinant adenovirus Ad-hTERT-EGFP could selectively infect 253J cells,with the infection rate associated with the increasing MOI of recombinant adenovirus (P<0.01).When MOI was 1,the infection rate was 8.3%;when MOI was 1000,the infection rate was 100.0%.GCV significantly inhibited the growth of both cell lines (253J and MRC-5) infected with Ad-CMV-HSV/tk and the growth of only 253J infected with Ad-hTERT-HSV/tk (P<0.001).The survival rate of 253J was correlated with the concentration of both the prodrugs and MOI of recombinant adenovirus (P<0.01).When MOI was 1,with 1 μmol/L GCV,the survival rate of 253J was 95.4%;when MOI was 100,with 1000 μmol/L GCV,the survival rate of 253J was 6.1%.Conclusion Recombinant adenovirus vector containing EGFP can report the transfection rate accurately and easily.Adenoviral vector containing hTERT promoter for the HSV/tk plus GCV treatment appears to be highly selective in killing bladder cancer cell line in vitro.7 refs.2 tabs.
引用
收藏
页码:201 / 202
页数:2
相关论文
共 50 条
  • [11] Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer
    X Yin
    B Yu
    Z Tang
    B He
    J Ren
    X Xiao
    W Tang
    Cancer Gene Therapy, 2013, 20 : 77 - 81
  • [12] Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer
    Yin, X.
    Yu, B.
    Tang, Z.
    He, B.
    Ren, J.
    Xiao, X.
    Tang, W.
    CANCER GENE THERAPY, 2013, 20 (02) : 77 - 81
  • [13] Effects of HSV-Tk Mediated Suicide Gene Therapy on Normal Brain Cells
    Al Hossain, Jubayer
    Ystaas, Lars Romo
    Mrdalj, Jelena
    Vaelk, Kristjan
    Riecken, Kristoffer
    Fehse, Boris
    Bjerkvig, Rolf
    Gronli, Janne
    Miletic, Hrvoje
    MOLECULAR THERAPY, 2016, 24 : S187 - S188
  • [14] An experimental study on cervix cancer with combination of HSV-TK/GCV suicide gene therapy system and 60Co radiotherapy
    Daozhen Chen
    Qiusha Tang
    BMC Cancer, 10
  • [15] HSV-tk/GCV gene therapy mediated by EBV-LMPI for EBV-associated cancer
    Yang Lifang
    Tang Min
    Ai Midan
    Cao Ya
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2008, 27 (1)
  • [16] An experimental study on cervix cancer with combination of HSV-TK/GCV suicide gene therapy system and 60Co radiotherapy
    Chen, Daozhen
    Tang, Qiusha
    BMC CANCER, 2010, 10
  • [17] Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system
    Bai, SC
    Du, LP
    Liu, WQ
    Whittle, IR
    He, L
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (02) : 455 - 459
  • [18] Hsv-tk suicide gene modified mesenchymal stem cells mediated tumour therapy
    Matuskova, Miroslava
    Pastorakova, Andrea
    Hlubinova, Kristina
    Hunakova, Lubica
    Altanerova, Veronika
    Altaner, Cestmir
    Kucerova, Lucia
    HUMAN GENE THERAPY, 2008, 19 (10) : 1184 - 1184
  • [19] Combination gene therapy with adenoviral vector-mediated HSV-tk plus GCV and IL-12 in an orthotopic mouse model for prostate cancer
    Nasu, Y
    Bangma, CH
    Hull, GW
    Yang, G
    Wang, J
    Shimura, S
    McCurdy, MA
    Ebara, S
    Lee, HM
    Timme, TL
    Thompson, TC
    PROSTATE CANCER AND PROSTATIC DISEASES, 2001, 4 (01) : 44 - 55
  • [20] Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer
    Chhikara, M
    Huang, HX
    Vlachaki, MT
    Zhu, XH
    Teh, B
    Chiu, KJ
    Woo, S
    Berner, B
    Smith, EO
    Oberg, KC
    Aguilar, LK
    Thompson, TC
    Butler, EB
    Aguilar-Cordova, E
    MOLECULAR THERAPY, 2001, 3 (04) : 536 - 542